• Policy
• Multinational companies have more drugs for PVA
• by Lee, Hye-Kyung Oct 28, 2021 05:58am

• Policy
• Development of generics for DPP4+SGLT2 has begun
• by Lee, Tak-Sun Oct 27, 2021 05:49am

• Policy
• Samsung Bio’s Moderna vaccine receives GMP certification
• by Lee, Tak-Sun Oct 27, 2021 05:49am

• Policy
• Dongkook started developing Dukarb's IMD
• by Lee, Tak-Sun Oct 26, 2021 05:53am

• Policy
• Up to 500 ppl will be allowed at events from next month
• by Kim, Jung-Ju Oct 26, 2021 05:53am

• Policy
• Hanmi Pharmaceutical's Esomezole Plus has been approved
• by Lee, Tak-Sun Oct 26, 2021 05:53am

• Policy
• HIRA “Will improve RSA and prior authorization system”
• by Lee, Hye-Kyung Oct 25, 2021 05:50am

• Policy
• Domestic approval for Pfizer's Cibinqo (PO) is imminent
• by Lee, Tak-Sun Oct 22, 2021 05:45am

• Policy
• "Annual unused drug returns record ₩2.7 trillion”
• by Lee, Jeong-Hwan Oct 22, 2021 05:45am

• Policy
• There are expectations & concerns about ordering research
• by Lee, Jeong-Hwan Oct 22, 2021 05:44am